8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      A nomogram model for predicting prognosis of obstructive colorectal cancer

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          The prognosis of obstructive colorectal cancer (oCRC) is worse than that of nonobstructive colorectal cancer. However, no previous study has established an individualized prediction model for the prognosis of patients with oCRC. We aimed to screen the factors that affect the prognosis of oCRC and to use these findings to establish a nomogram model that predicts the individual prognosis of patients with oCRC.

          Methods

          This retrospective study collected data of 181 patients with oCRC from three medical hospitals between February 2012 and December 2017. Among them, 129 patients from one hospital were used as the training cohort. Univariate and multivariate analyses were used in this training cohort to select independent risk factors that affect the prognosis of oCRC, and a nomogram model was established. The other 52 patients from two additional hospitals were used as the validation cohort to verify the model.

          Results

          Multivariate analysis showed that carcinoembryonic antigen level ( p = 0.037, hazard ratio [HR] = 2.872 [1.065–7.740]), N stage (N1 vs. N0, p = 0.028, HR = 3.187 [1.137–8.938]; N2 vs. N0, p = 0.010, HR = 4.098 [1.393–12.051]), and surgical procedures ( p = 0.002, HR = 0.299 [0.139–0.643]) were independent prognostic factors of overall survival in patients with oCRC. These factors were used to construct the nomogram model, which showed good concordance and accuracy.

          Conclusion

          Carcinoembryonic antigen, N stage, and surgical method are independent prognostic factors for overall survival in patients with oCRC, and the nomogram model can visually display these results.

          Related collections

          Most cited references42

          • Record: found
          • Abstract: found
          • Article: not found

          Cancer Statistics, 2021

          Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths in the United States and compiles the most recent data on population-based cancer occurrence. Incidence data (through 2017) were collected by the Surveillance, Epidemiology, and End Results Program; the National Program of Cancer Registries; and the North American Association of Central Cancer Registries. Mortality data (through 2018) were collected by the National Center for Health Statistics. In 2021, 1,898,160 new cancer cases and 608,570 cancer deaths are projected to occur in the United States. After increasing for most of the 20th century, the cancer death rate has fallen continuously from its peak in 1991 through 2018, for a total decline of 31%, because of reductions in smoking and improvements in early detection and treatment. This translates to 3.2 million fewer cancer deaths than would have occurred if peak rates had persisted. Long-term declines in mortality for the 4 leading cancers have halted for prostate cancer and slowed for breast and colorectal cancers, but accelerated for lung cancer, which accounted for almost one-half of the total mortality decline from 2014 to 2018. The pace of the annual decline in lung cancer mortality doubled from 3.1% during 2009 through 2013 to 5.5% during 2014 through 2018 in men, from 1.8% to 4.4% in women, and from 2.4% to 5% overall. This trend coincides with steady declines in incidence (2.2%-2.3%) but rapid gains in survival specifically for nonsmall cell lung cancer (NSCLC). For example, NSCLC 2-year relative survival increased from 34% for persons diagnosed during 2009 through 2010 to 42% during 2015 through 2016, including absolute increases of 5% to 6% for every stage of diagnosis; survival for small cell lung cancer remained at 14% to 15%. Improved treatment accelerated progress against lung cancer and drove a record drop in overall cancer mortality, despite slowing momentum for other common cancers.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

            This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Colon Cancer focuses on systemic therapy options for the treatment of metastatic colorectal cancer (mCRC), because important updates have recently been made to this section. These updates include recommendations for first-line use of checkpoint inhibitors for mCRC, that is deficient mismatch repair/microsatellite instability-high, recommendations related to the use of biosimilars, and expanded recommendations for biomarker testing. The systemic therapy recommendations now include targeted therapy options for patients with mCRC that is HER2-amplified, or BRAF V600E mutation–positive. Treatment and management of nonmetastatic or resectable/ablatable metastatic disease are discussed in the complete version of the NCCN Guidelines for Colon Cancer available at NCCN.org . Additional topics covered in the complete version include risk assessment, staging, pathology, posttreatment surveillance, and survivorship.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Cancer incidence and mortality in China, 2014.

              National Central Cancer Registry of China (NCCRC) updated nationwide cancer statistics using population-based cancer registry data in 2014 collected from all available cancer registries.
                Bookmark

                Author and article information

                Contributors
                lizhongxin96@163.com
                Journal
                World J Surg Oncol
                World J Surg Oncol
                World Journal of Surgical Oncology
                BioMed Central (London )
                1477-7819
                2 December 2021
                2 December 2021
                2021
                : 19
                : 337
                Affiliations
                [1 ]GRID grid.440208.a, ISNI 0000 0004 1757 9805, Department of Emergency, , Hebei General Hospital, ; No. 348 Heping West Road, Shijiazhuang, 050051 Hebei China
                [2 ]GRID grid.414252.4, ISNI 0000 0004 1761 8894, Department of Anorectal Surgery, , Huanghua General Hospital, ; No. 262 Xinhua Road, Huanghua, 061100 Hebei China
                [3 ]GRID grid.440208.a, ISNI 0000 0004 1757 9805, Department of Oncology, , Hebei General Hospital, ; Shijiazhuang, 050051 Hebei China
                [4 ]GRID grid.452582.c, Second Department of Surgery, , The Fourth Hospital of Hebei Medical University, ; No. 12 Jiankang Road, Shijiazhuang, 050011 Hebei China
                [5 ]GRID grid.470181.b, Department of Anorectal Surgery, , The First Hospital of Shijiazhuang, ; No. 36, Fanxi Road, Shijiazhuang, 050011 Hebei China
                [6 ]GRID grid.452582.c, Department of Plastic Surgery, , The Fourth Hospital of Hebei Medical University, ; Shijiazhuang, 050011 Hebei China
                [7 ]GRID grid.452582.c, Department of Anesthesiology, , The Fourth Hospital of Hebei Medical University, ; No. 12 Jiankang Road, Shijiazhuang, 050011 Hebei China
                [8 ]GRID grid.16821.3c, ISNI 0000 0004 0368 8293, Department of General Surgery, Shanghai Ninth People’s Hospital, , Shanghai Jiao Tong University School of Medicine, ; Shanghai, 200011 China
                [9 ]GRID grid.452458.a, Department of General Surgery, , The First Affiliated Hospital of Hebei Medical University, ; No. 89 Donggang Road, Shijiazhuang, 050000 Hebei China
                Article
                2445
                10.1186/s12957-021-02445-6
                8638364
                34857001
                2644d569-bfc4-43b9-85da-c87d0e2d9202
                © The Author(s) 2021

                Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

                History
                : 24 January 2021
                : 23 October 2021
                Categories
                Research
                Custom metadata
                © The Author(s) 2021

                Surgery
                colorectal cancer,obstruction,prognosis,nomogram
                Surgery
                colorectal cancer, obstruction, prognosis, nomogram

                Comments

                Comment on this article